Newsletter | November 19, 2019

11.19.19 -- Moving Forward With Immunotherapies For Cancer

 
Industry Insights
Improving Cell Image Analysis Workflows Through Machine Learning
Article | By Will Marshall, GE Healthcare Life Sciences

Artificial intelligence (AI) provides exciting opportunities for fast, accurate, and unbiased cell image analysis. Read this guide to machine learning in high content analysis and see the benefits AI can bring to your automated cell imaging.

Moving Forward With Immunotherapies For Cancer
Article | By Barbara Gilmore, Frost & Sullivan, Bio-Rad Laboratories, Inc.

Industry experts joined a panel at Frost & Sullivan's Virtual Think Tank recently to discuss the current state of immunotherapies, implications of research and development occurring today, key challenges, and future approaches to the targeted use of the immune system in cancer treatment. Read their thoughts on immunotherapies and the critical role for the immune system to play, especially in the advanced stages of cancer, since traditional standard-of-care therapies do often work fairly well.

First-In-Human Trials: A Make-Or-Break Milestone For Small Biopharmas
Article | Thermo Fisher Scientific

Whether biopharmaceutical companies have one candidate or 100, the directive is clear: moving quickly into FIH testing is essential. But, how?

Improve Data Integrity And Quality For Life Sciences
Infographic | Dassault Systemes Americas

Improve data integrity and quality, ensure IP protection, increase efficiency, and collaboration and enable faster and better decision making.

Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.